Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
The compliance risks of giving referral sources software or equipment to ensure the security of protected health information.
Lab leaders are at the greatest risk of HIPAA violations when they get complacent about privacy training.
While overpayments may not be your fault, they expose your lab to the risk of liability under the Affordable Care Act.
While ChatGPT has its place, allowing lab staff to use it exposes you to liabilities—here are some ways to manage the risks involved.
Hiring, retaining, or simply doing business with the wrong people may expose your lab to significant financial penalties.
A False Claims Act whistleblower lawsuit can do significant damage to your lab and its reputation, even if the case lacks truth and merit.
A code of conduct for sales and marketing staff is essential to allow staff to do their jobs while avoiding liability risk.
Key points to educate your staff on when it comes to patient requests for test records and other protected health information.
How to avoid eight of the most common liability pitfalls when it comes to sales and marketing operations in your lab.